Quinuclidine derivatives as muscarinic M3 receptor antagonists

Details for Australian Patent Application No. 2008356409 (hide)

Owner AstraZeneca AB Pulmagen Therapeutics (Synergy) Limited

Inventors Ford, Rhonan Lee; Mather, Andrew Nigel; Bull, Richard James; Skidmore, Elizabeth Anne; Mete, Antonio

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008356409

PCT Pub. Number WO2009/138707

Filing date 13 May 2008

Wipo publication date 19 November 2009

Acceptance publication date 19 January 2012

International Classifications

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/138707 Priority application(s): WO2009/138707

19 January 2012 Application Accepted

  Published as AU-B-2008356409

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008356428-Roughing grinding wheel

2008356312-Antitumor agent, kit, and method for treating cancer